	fenofibrate capsule	25.235615299045868
	separately micronize fenofibrate	24.968062873603213
	separately micronized fenofibrate	19.428069502000824
¡°	therapeutic fenofibrate composition	17.44439671095861
	propose fenofibrate formulation	17.441045486106272
	fenofibrate SLS mixture	15.864414648511985
	phrase fenofibrate solid surfactant mixture	11.138479868277857
	exclusive licensee	7.441883643725314
	co micronization	6.650462779970258
	anda	2.77154311091979
	proposal	2.7516397249920774
	submission	2.7225024061823704
	generic micronized formulation	2.0281297825382083
	hyperlipidemia	2.0149985020322054
	hypercholesterolemia	2.0149985020322054
¡°	TRICOR	2.0149985020322054
	lactose	2.0149985020322054
	co micronized mixture	1.837886780697326
	gelatin capsule	1.3472936884457387
	excipient	1.2964378902990836
	submit-(A	1.0080989530929783
	starch	0.810232684763125
	ï¿½ï¿½	0.6147421441661969
	intimate mixture	0.6133937628686901
	cholesterol drug	0.5209107794112227
	sodium lauryl sulfate	0.5146005293525212
	bioavailability	0.47855202076190795
	less fifteen micron	0.27817665345329934
	Title	0.1683084778073343
	IV certification	0.16316838482619797
	wherein mean particle size	0.15394749617012432
	N.D.Ill	0.14370995948690127
	vivo	0.12434417707202419
	approve NDA	0.1060300184280763
	lexis	0.09593815087928306
	dissolution rate	0.09016973986912562
	paragraph iv certification	0.09004642364108544
	Federal Food Drug Cosmetic Act	0.05312668665105118
	ANDA applicant	0.04089935740605514
	therapeutic composition	0.03331283048811431
	Illinois	0.028945204560631883
	prior art formulation	0.028335754548317858
	United States Code	0.02718561980433409
	FDA approval	0.017449904935037473
	noninfringement	0.014972961396834683
	assignee	0.01428212758296984
	Abbreviated New Drug Application	0.012916152008551363
	Lourie	0.01278786036694114
	patented composition	0.011360132370063487
	United States Food Drug Administration	0.01099845474963731
	alteration	0.009386026756633968
	dosage form	0.0071864204061326915
	notice letter	0.007099876059532999
	generic version	0.006800275127734999
	complaint	0.006402662767888177
	detailed statement	0.006345251424004588
	newly add form	0.0062017014781483885
	equivalent	0.005763045881897605
	detailed example	0.004761460892457394
	Northern District	0.0042635861221735
	significantly great extent	0.0030622953192140025
	property	0.0026323070919576043
	manufacturer	0.0025029147585526323
	anything	0.0025029147585526323
	datum	0.0023801903623972276
	oral treatment	0.002255681603023782
	doctrine	0.00207416062097441
	plaintiff	0.0017641931805440648
	December	0.0016787571144497456
	amendment	0.0013762577539989439
	sale	0.001308639788290901
	pertinent part	0.0006574747779609752
	commercial manufacture	0.0006461928976099523
	defendant	0.0005496076372196639
	independent	0.0003908639549686705
	summary judgment	0.00032779179868547335
	patented subject matter	0.0002690796322165387
	method	0.00025100581823145904
	section	0.00018938481625215337
	description	0.0001793793199349966
	prosecution history	0.00015401940573371928
	response	0.00012872012131016152
	favor	8.230419924873305e-05
	suit	4.142711117858093e-05
	factual legal basis	3.5282263819218863e-05
	three action	9.677038557746508e-06
	opinion	6.622216860984037e-06
	Idaho	4.174323697693859e-06
	application	1.0985298635689344e-06
	cite prior art	2.684305723805195e-07
	one	1.3769613655601147e-07
	use	6.92690742490748e-09
	district court	3.681331966458203e-09
	invention	8.676440060056938e-10
	Court	0.0
	Appeals	0.0
